InvestorsHub Logo
Followers 71
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: shell3 post# 3929

Wednesday, 08/08/2018 12:51:55 PM

Wednesday, August 08, 2018 12:51:55 PM

Post# of 16697
Keeping in mind, Zeptometrix (a Private Company) has zero to do with the Collins story other than a link back to a failed deal with Zeptometrix. The good thing is that deal (thanks to Guy LaTorre) never cost us any money. The real point is Collins was wrapped up in a publicly traded company and utilized his family friends plan to his benefit and loss to common shareholders. Plus the tiny biotech had 17 years prior experience in the pharma business before their Phase 2 catastrophic failure. Nash Pharmacueticals can't even be considered tiny or have experience. It's a company on paper only. Being valued at more than Breathtec's accomplishments to date - half the outstanding plus another 10 Million shares or more in Private Placements for starters. It's crazy! I think I've summed up where we are as a company, and where we're headed > to court.

/////AMG

It's A Real Movie



Take Your Best Screenshot